WHO ICTRP trial
Risk prediction of thromboembolism disease for patients underwent chemotherapy…
ChiCTR1800020314 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800020314 |
|---|---|
| Public title | Risk prediction of thromboembolism disease for patients underwent chemotherapy: a cases based cohort study |
| Scientific title | Risk prediction of thromboembolism disease for patients underwent chemotherapy: a cases based cohort study |
| Primary sponsor | Affiliated Hospital of Dalian Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Relative factors research |
| Phase | Other |
| Countries | China |
| Conditions | thromboembolism disease |
| Interventions | Cohorts:Nil |
| Registration date | Dec 23, 2018 |
| Target size | Cohorts:450 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: